NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis

Figure 5

Construction of nomogram and evaluation of its prediction ability. (a) A nomogram was constructed based on independent factors to predict the 1-year, 3-year, and 5-year overall survival in HCC patients. (b) Calibration curve for the prediction of 1-year, 3-year, and 5-year survival in HCC patients. (c) ROC curve analysis of different clinical factors in complete dataset. (d) Decision curve analysis of the nomogram. -axis represents the percentage of threshold probability, and -axis represents the net benefit.

(a)

(b)

(c)

(d)